Neuroscience

The Neurosciences Program has extensive experience in the study of the most prevalent and disabling neurodegenerative diseases with dementia and movement disorders.  

Our research focuses on the study of Alzheimer's disease, Parkinson's disease and treatment-resistant epilepsies. Currently these diseases do not have therapies capable of curing or delaying their evolution and represent a serious public health problem.

We have advanced technology for the genomic study of these diseases and can analyze genetic alterations and risk factors associated with poor response to drugs. At the same time, we have other cutting-edge techniques to develop specific animal models of the disease that have led to the design of new treatments and the generation of several patents.

The program is made up of a multidisciplinary team of expert biologists, biochemists, physicians, pharmacists, engineers, psychologists, bioinformaticians, etc. The constant interaction with the professionals of the Clínica Universidad de Navarra allows us to develop high impact projects that can reach patients as soon as possible. This translational work is reflected in our participation in the early phases of clinical trials.

Program researchers are members of the Center for Biomedical Research Network on Neurodegenerative Diseases (CiberNed). Due to their recognized trajectory, they maintain extensive national and international collaborations that promote the exchange of resources and technology, and enrich the training of students and predoctoral and postdoctoral researchers. 

The renowned research work of the program is reflected in the funding received by various national and international agencies such as the Michael J Fox Foundation, Hereditary Disease Foundation, European Research Council or the European Commission (7th Framework Program). Another fundamental pillar is the support received from donors and other fundraising initiatives.